Scientific Programme Committee

Niki Karavitaki (UK)

Niki Karavitaki (UK)

Dr. Niki Karavitaki is a Clinical Associate Professor at the Institute of Metabolism and Systems Research at the University of Birmingham, Honorary Consultant Endocrinologist at the Queen Elizabeth Hospital in Birmingham and Research and Education Lead at the Centre for Endocrinology, Diabetes and Metabolism (CEDAM). Her clinical and research interests focus on hypothalamo-pituitary disease and she is the co-lead of the Pituitary Service and Pituitary MDT at the Queen Elizabeth Hospital, one of the largest in the UK. She has published extensively in her field with highly cited papers and has authored a number of chapters in prestigious books. She leads the Clinical Academic Training in Endocrinology and Diabetes in the University of Birmingham and she is the clinical lead of the ESE Focus Area on Pituitary and Neuroendocrinology (https://www.birmingham.ac.uk/research/cedam/our-people.aspx).

Justo Castaño (Spain)

Justo Castaño (Spain)

Justo P. Castaño (1964) is Professor of Cell Biology in the Department of Cell Biology, Physiology and Immunology of the University of Córdoba (UCO) and Head of the Hormones and Cancer group of the Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Spain. He graduated and obtained his PhD in Biological Sciences at UCO (1993) and completed his postdoctoral training through a Fulbright Fellowship at the Medical University of South Carolina (USA). His team investigates the cellular and molecular basis of neuroendocrine tumors (NETs), pituitary tumors, pancreatic adenocarcinoma, and other cancers, exploring the emerging pathophysiologic and oncogenic role of hormone receptors and alternative splicing. His original work on the regulation of pituitary and neuroendocrine cell types by neuropeptides and their receptors under normal and pathological conditions advanced with the discovery of aberrant variants of somatostatin receptor subtype 5 (SST5TMD4) and ghrelin (In1-ghrelin). These variants, which are overexpressed in different types of tumors, prompted his team to investigate in more detail the process of alternative splicing and its regulation in different cancers. Dr. Castaño has published 215 indexed scientific and 66 book chapters and has contributed more than 420 communications to congresses. His work has received > 5700 citations (H-index 40). He has obtained continued competitive funding support from national institutions (MINECO) since 2002 and has gained also funding support from diverse private companies, foundations and associations. He has directed 20 PhD thesis and has registered 11 international patents. He actively participates in national and international networking actions, and in activities to disseminate research and scientific advances. He has received numerous invitations to participate as speaker in national and international meetings: ESE, ENETS, GH&IGFI Society, ENEA, Spanish SEEN and GETNE. He serves as a referee/panel member of several Spanish and International funding agencies, and as Editor in various journals (Endocrine Views, Sci Rep, J Clin Med, Endocr Diab Nutr), and has been Senior/board editor for J Endocrinol-J Mol Endocrinol J Clin Endocrinol Metab, Front Endocrinol, Mol Cell Endocrinol, Endocrine, J Alzh Dis, etc... He is member of the Executive Committee of the GETNE, and serves in the Advisory Board of the ENETS. He has been President of the Iberian Association of Comparative Endocrinology (AIEC) and member of the Executive Committee of SEEN and ESE (acting Secretary). He has Chaired several Program Organizing Committees (ECE2013; SEEN2015; GETNE2017), and served in various POCs. He has served as Vice-rector of Scientific Policy and Campus of Excellence of the UCO and General Coordinator of the Campus of International Excellence in Agri-food ceiA3 (2012-14) and Vice-Director (2009-11) and Director (2015-19) of the IMIBIC

Gerald Raverot (France)

Gerald Raverot (France)

Dr. Raverot is Professor in Endocrinology at Lyon 1 University and is chief of the Reference Center of Rare Pituitary Disease and the Endocrine Department at Hospices Civils of Lyon. He leads a research team dedicated to “Pathophysiology of pituitary tumors” at the INSERM Research Center. He coordinated the European Society of Endocrinology guidelines on aggressive pituitary tumors and carcinoma. His major research interests are pituitary tumor pathogenesis and identification of prognosis markers allowing the development of potential new therapies. He served on boards of the French Society of Endocrinology, the Endocrine Society, and the European Society of Endocrinology, and has been elected to the European Neuroendocrine Association executive committee.

Monica Gadelha (Brazil)

Monica Gadelha (Brazil)

Mônica Gadelha is Professor of Endocrinology at the Medical School of the Universidade Federal do Rio de Janeiro (UFRJ) and directs the Neuroendocrine Research Center at Hospital Universitário Clementino Fraga Filho of the UFRJ. Dr Gadelha also heads the Neuroendocrine Section and the Molecular Genetics Laboratory of the Instituto Estadual do Cérebro Paulo Niemeyer. She is president of the Pituitary Society, president of the international committee of the Brazilian Society of Endocrinology and Metabolism, researcher at Brazil’s Conselho Nacional de Desenvolvimento Cientifico e Tecnológico and a member of the Brazilian National Academy of Medicine. She graduated at the UFRJ and performed the research and experimental part of her PhD at the University of Illinois at Chicago, IL, USA, receiving her PhD from the UFRJ. Major research interests include the molecular pathogenesis, diagnosis, and treatment of pituitary tumours. Dr Gadelha has published 216 peer-reviewed journal articles and book chapters, including one book. She has served on the editorial boards and as a referee of several international journals and is also associate editor of the Journal of Clinical Endocrinology and Metabolism.

Cristina Capatina (Romania)

Cristina Capatina (Romania)

Dr. Cristina Capatina is consultant in endocrinology at the Pituitary and Neuroendocrine diseases Department at „CI Parhon” National Institute of Endocrinology in Bucharest and senior lecturer in endocrinology at Carol Davila UMPh Bucharest, Romania. She graduated in 1999 and qualified as specialist in endocrinology in 2007. Since 2007 she has been an active member of the academic community of Carol Davila UMPh. Dr Capatina has been awarded 2 grants for clinical fellowship at Oxford University- Oxford Center for Diabetes, Endocrinology and Metabolism, OCDEM. Her main research interests are neuroendocrinology and pituitary pathology. Also her clinical work mainly involves pituitary patients since they represent the majority of cases followed up in the Pituitary and Neuroendocrine Diseases Department where she activates. She participated as investigator in several international clinical studies for pituitary patients. She has published numerous papers related to pituitary pathology both in collaboration with the OCDEM team and with the endocrinology research team at Carol Davila UMPh and functions as a reviewer for more than 40 top journals in this field.